Fintel reports that on February 12, 2025, Morgan Stanley downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Thanks to the proximity to top research universities like Harvard and the Massachusetts Institute of Technology, plus venture-capital firms like Flagship Pioneering, Atlas Venture, 5AM Ventures ...

and invest in new biotech start-ups bringing new medicines to patients," according to the venture capital firm. In a blog post, Atlas partner Bruce Booth said that the fundraising was "the ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...